openPR Logo
Press release

Tumor Necrosis Factor Receptor

02-23-2018 12:51 PM CET | Health & Medicine

Press release from: WiseGuy Research consultants Pvt Ltd.

/ PR Agency: WISEGUY RESEARCH CONSULTANTS PVT LTD
Tumor Necrosis Factor

Tumor Necrosis Factor

WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Tumor Necrosis Factor - Pipeline Review, H2 2017”

Tumor Necrosis Factor

Overview

Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed by Companies.

The latest report Tumor Necrosis Factor Receptor Superfamily Member 18 - Pipeline Review, H1 2018, outlays comprehensive information on the Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/2841823-tumor-necrosis-factor-receptor-superfamily-member-18-glucocorticoid-induced-tumor

Top Companies mentioned

Apogenix AG

Bristol-Myers Squibb Co

Checkpoint Therapeutics Inc

GigaGen Inc

Incyte Corp

Leap Therapeutics Inc

MedImmune LLC

Tumor Necrosis Factor Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Tumor Necrosis Factor    - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Tumor Necrosis Factor   , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

TNFSF18 is involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. It mediated NF-kappa-B activation via the TRAF2/NIK pathway. The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are 2, 6, 4 and 2 respectively.

Tumor Necrosis Factor pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Tumor Necrosis Factor - Competitive Analysis

Key players are making innovative developments in Tumor Necrosis Factor industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Tumor Necrosis Factor.

The pipeline guide reviews pipeline therapeutics for Tumor Necrosis Factor by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Tumor Necrosis Factor therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Tumor Necrosis Factor therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Tumor Necrosis Factor.

.Continued

For Detailed Reading Please visit @  https://www.wiseguyreports.com/reports/2841823-tumor-necrosis-factor-receptor-superfamily-member-18-glucocorticoid-induced-tumor

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tumor Necrosis Factor Receptor here

News-ID: 955582 • Views: 151

More Releases from WiseGuy Research consultants Pvt Ltd.

Data Center Colocation Market 2019: Size, Share, Demand, Trends, Growth and 2025 …
Global Data Center Colocation Industry New Study On “2019-2025 Data Center Colocation Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database Data center operators face an increasing need for scalable data center infrastructure, which enables the scaling of critical data center components as and when the demand increases. The data center colocation provides data center space, along with the power and cooling infrastructure, which address
Temperature Logger Market 2019 Trends, Research, Analysis & Review Forecast 2025
Global Temperature Logger Industry New Study On “2019-2025 Temperature Logger Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database This report studies the global Temperature Logger market status and forecast, categorizes the global Temperature Logger market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The
Building Management System Market Analysis 2018 (By Segment, Key Players and App …
Global Building Management System (BMS )Industry Latest Report on Building Management System Market Global Analysis & 2022 Forecast Research Study In this report, the global BMS market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Global BMS market competition by top manufacturers, with production, price, revenue (value) and market share
Sports and Athletic Socks Market: Global Industry Analysis and Opportunity Asses …
Global Sports and Athletic Socks Industry New Study On “2018-2025 Sports and Athletic Socks Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” Added to Wise Guy Reports Database This report studies the global market size of Sports and Athletic Socks in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sports and Athletic Socks in these regions.

All 5 Releases


More Releases for Tumor

Rising Prevalence of brain Tumor Couple with Geriatric Populations supporting gr …
Albany, NY, 26th February : Recent research and the current scenario as well as future market potential of "Brain Tumor Therapeutics: Global Markets to 2023" globally. ResearchMOZ.us has published a fresh report to its vast repository titled “Global Brain Tumor Therapeutics Market - Segmented by Type of Cancer and Therapeutics - Growth, Trends and Forecasts 2018-2026” to its offerings. The report provides comprehensive analysis of the global tumor therapeutics market in the
Global Tumor Ablation Devices Market - Insights
Increasing prevalence of various cancer globally rising the demand of treatment through ablation procedure due to its lesser/minimal side effect rates over other procedures intended to boost the tumor ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the world, with approximately 14 million new cases reported worldwide in 2012. Click To Continue Reading: https://www.coherentmarketinsights.com/market-insight/tumor-ablation-devices-market-1270 Tumor Ablation devices market
Global Tumor Ablation Devices Market - Insights
Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators,
Tumor Ablation Market: Industry Evolution/Development
A recent study by Transparency Market Research (TMR) has detected that the competition in the global tumor ablation market is intense, in a fragmented scenario with the presence of a number of participants. That being said, there are plenty of growth opportunities too in the market for tumor ablation, which will continue to attract pharmaceutical companies and further intensify the competition. The TMR report projects the global tumor ablation market
Personalised tumor vaccines keep cancer in check
Throughout the last decade, novel cancer therapeutics has seen tremendous developments, through targeting tumor cell-intrinsic pathways, as well as targeting tumor cell-extrinsic factors such as growth factors. Notable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further demonstrates the critical role of T-cells in cancer control and rejection. However, many patients still do not respond to checkpoint inhibitor therapies. This creates the need for
Global Neuroendocrine Tumor Treatment Market
The Global Neuroendocrine Tumor Treatment Market was valued at US$ 1,197.3 million in 2016 and is projected to expand at a CAGR of 10.5% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Better diagnostic techniques and products in pipeline are expected to be major factors driving growth of the global neuroendocrine tumor treatment market over the foreseeable future. Neuroendocrine Tumor (NET) are diagnosed